Asma @page { } table { border-collapse:collapse; border-spacing:0; empty-cells:show } td, th { vertical-align:top; font-size:12pt;} h1, h2, h3, h4, h5, h6 { clear:both } ol, ul { margin:0; padding:0;} li { list-style: none; margin:0; padding:0;} <!-- "li span.odfLiEnd" - IE 7 issue--> li span. { clear: both; line-height:0; width:0; height:0; margin:0; padding:0; } span.footnodeNumber { padding-right:1em; } span.annotation_style_by_filter { font-size:95%; font-family:Arial; background-color:#fff000; margin:0; border:0; padding:0; } * { margin:0;} .gr1 { color:#ffffff; font-size:18pt; font-style:normal; font-weight:normal; line-height:100%; margin-bottom:0cm; margin-left:0cm; margin-right:0cm; margin-top:0cm; padding-bottom:0.125cm; padding-left:0.25cm; padding-right:0.25cm; padding-top:0.125cm; text-align:left ! important; text-indent:0cm; text-shadow:none; text-decoration:none ! important; writing-mode:lr-tb; min-height:1.27cm;} .gr10 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr11 { color:#ffffff; font-size:18pt; font-style:normal; font-weight:normal; line-height:100%; margin-bottom:0cm; margin-left:0cm; margin-right:0cm; margin-top:0cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; padding-top:0.13cm; text-align:left ! important; text-indent:0cm; text-shadow:none; text-decoration:none ! important; writing-mode:lr-tb; } .gr12 { font-size:24pt; writing-mode:lr-tb; } .gr13 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr14 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr15 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr16 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr17 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr18 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr19 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr2 { color:#ffffff; font-size:18pt; font-style:normal; font-weight:normal; line-height:100%; margin-bottom:0cm; margin-left:0cm; margin-right:0cm; margin-top:0cm; padding-bottom:0.125cm; padding-left:0.25cm; padding-right:0.25cm; padding-top:0.125cm; text-align:left ! important; text-indent:0cm; text-shadow:none; text-decoration:none ! important; writing-mode:lr-tb; min-height:1.27cm;} .gr20 { color:#ffffff; font-size:18pt; font-style:normal; font-weight:normal; line-height:100%; margin-bottom:0cm; margin-left:0cm; margin-right:0cm; margin-top:0cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; padding-top:0.13cm; text-align:left ! important; text-indent:0cm; text-shadow:none; text-decoration:none ! important; writing-mode:lr-tb; } .gr21 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr22 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr3 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr4 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr5 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr6 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr7 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr8 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr9 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .P1 { font-size:14pt; } .P10 { margin-left:0cm; margin-right:0cm; text-align:center ! important; text-indent:0cm; writing-mode:lr-tb; } .P11 { margin-left:0cm; margin-right:0cm; text-align:right ! important; text-indent:0cm; } .P12 { margin-left:0cm; margin-right:0cm; text-align:right ! important; text-indent:0cm; writing-mode:lr-tb; } .P13 { margin-left:0cm; margin-right:0cm; text-indent:0cm; } .P14 { margin-left:0cm; margin-right:0cm; margin-top:0.246cm; margin-bottom:0cm; text-indent:0cm; } .P15 { margin-left:0.952cm; margin-right:0cm; margin-top:0.246cm; margin-bottom:0cm; text-indent:-0.952cm; } .P16 { margin-left:0cm; margin-right:0cm; line-height:100%; text-indent:0cm; } .P17 { margin-left:0cm; margin-right:0cm; line-height:100%; text-align:center ! important; text-indent:0cm; } .P18 { margin-left:0cm; margin-right:0cm; margin-top:0.617cm; margin-bottom:0cm; text-indent:0cm; } .P19 { margin-left:0cm; margin-right:0cm; margin-top:0.705cm; margin-bottom:0cm; text-indent:0cm; } .P2 { text-align:right ! important; font-size:14pt; } .P20 { margin-left:0cm; margin-right:0cm; margin-top:0.529cm; margin-bottom:0cm; text-align:justify ! important; text-indent:0cm; } .P21 { margin-left:0cm; margin-right:0cm; margin-top:0.352cm; margin-bottom:0cm; line-height:100%; text-align:justify ! important; text-indent:0cm; } .P22 { margin-left:0cm; margin-right:0cm; margin-top:0.352cm; margin-bottom:0cm; text-align:justify ! important; text-indent:0cm; } .P23 { margin-left:4.445cm; margin-right:0cm; margin-top:0.352cm; margin-bottom:0cm; text-align:justify ! important; text-indent:-0.635cm; } .P24 { margin-left:0cm; margin-right:0cm; margin-top:0.246cm; margin-bottom:0cm; text-align:justify ! important; text-indent:0cm; } .P25 { margin-left:0cm; margin-right:0cm; margin-top:0.211cm; margin-bottom:0cm; text-align:justify ! important; text-indent:0cm; } .P26 { margin-left:4.445cm; margin-right:0cm; margin-top:0.211cm; margin-bottom:0cm; text-align:justify ! important; text-indent:-0.635cm; } .P27 { margin-left:0cm; margin-right:0cm; margin-top:0.679cm; margin-bottom:0cm; text-align:justify ! important; text-indent:0cm; } .P28 { margin-left:0cm; margin-right:0cm; margin-top:0.617cm; margin-bottom:0cm; text-align:justify ! important; text-indent:0cm; } .P29 { margin-left:0cm; margin-right:0cm; margin-top:0.617cm; margin-bottom:0cm; line-height:90%; text-indent:0cm; } .P3 { writing-mode:lr-tb; } .P30 { margin-left:0cm; margin-right:0cm; margin-top:0.176cm; margin-bottom:0cm; line-height:90%; text-indent:0cm; } .P31 { margin-left:0cm; margin-right:0cm; margin-top:0.158cm; margin-bottom:0cm; line-height:90%; text-indent:0cm; } .P4 { text-align:center ! important; writing-mode:lr-tb; } .P5 { margin-left:0cm; margin-right:0cm; line-height:100%; text-indent:0cm; writing-mode:lr-tb; } .P6 { margin-left:0cm; margin-right:0cm; line-height:100%; text-align:center ! important; text-indent:0cm; writing-mode:lr-tb; } .P7 { margin-left:0cm; margin-right:0cm; line-height:100%; text-align:right ! important; text-indent:0cm; } .P8 { margin-left:0cm; margin-right:0cm; line-height:100%; text-align:right ! important; text-indent:0cm; writing-mode:lr-tb; } .P9 { margin-left:0cm; margin-right:0cm; text-indent:0cm; writing-mode:lr-tb; } .T10 { color:#ff0000; font-size:24pt; font-weight:bold; } .T11 { font-size:14pt; font-weight:bold; } .T12 { font-weight:bold; } .T13 { font-size:16pt; font-weight:bold; } .T14 { font-size:16pt; font-weight:bold; } .T15 { font-size:16pt; } .T16 { color:#0000cc; font-weight:bold; } .T17 { color:#0000cc; font-size:14pt; } .T18 { color:#0000cc; font-size:16pt; font-weight:bold; } .T19 { color:#ff0000; font-weight:bold; } .T2 { font-size:14pt; } .T20 { color:#ff0000; font-weight:bold; } .T21 { color:#ff0000; font-weight:bold; } .T22 { text-shadow:1pt 1pt; font-weight:bold; } .T23 { text-shadow:1pt 1pt; } .T24 { text-shadow:1pt 1pt; font-weight:bold; } .T25 { text-shadow:1pt 1pt; font-weight:bold; } .T26 { font-size:36pt; text-shadow:1pt 1pt; font-weight:bold; } .T27 { font-size:36pt; text-shadow:1pt 1pt; font-weight:bold; } .T28 { font-size:36pt; text-shadow:1pt 1pt; font-weight:bold; } .T29 { font-size:24pt; text-shadow:1pt 1pt; } .T3 { font-size:12pt; text-shadow:1pt 1pt; } .T30 { font-size:24pt; font-style:italic; text-shadow:1pt 1pt; } .T31 { font-size:20pt; font-style:italic; text-shadow:1pt 1pt; } .T32 { font-size:20pt; text-shadow:1pt 1pt; } .T33 { font-size:20pt; text-shadow:1pt 1pt; } .T34 { font-size:16pt; text-shadow:1pt 1pt; } .T35 { font-size:16pt; text-shadow:1pt 1pt; } .T36 { font-size:16pt; text-shadow:1pt 1pt; } .T37 { font-size:16pt; text-shadow:1pt 1pt; } .T38 { font-size:28pt; text-shadow:1pt 1pt; } .T39 { font-size:28pt; text-shadow:1pt 1pt; } .T4 { font-size:10pt; text-shadow:1pt 1pt; } .T40 { font-size:28pt; text-shadow:1pt 1pt; } .T41 { font-style:italic; text-shadow:1pt 1pt; } .T42 { text-shadow:1pt 1pt; } .T43 { color:#ffffcc; font-size:57pt; text-shadow:1pt 1pt; } .T44 { font-size:36pt; text-shadow:1pt 1pt; } .T45 { font-size:36pt; text-shadow:1pt 1pt; } .T46 { color:#ff3300; font-size:20pt; text-shadow:1pt 1pt; } .T47 { font-size:18pt; text-shadow:1pt 1pt; } .T48 { font-size:18pt; text-shadow:1pt 1pt; } .T49 { font-size:18pt; text-shadow:1pt 1pt; } .T5 { color:#eaeaea; font-size:12pt; text-shadow:1pt 1pt; } .T6 { color:#ccecff; font-size:54pt; text-shadow:1pt 1pt; font-weight:bold; } .T7 { text-shadow:1pt 1pt; } .T8 { font-size:28pt; text-shadow:1pt 1pt; } .T9 { font-size:28pt; text-shadow:1pt 1pt; font-weight:bold; } <!-- ODF styles with no properties representable as CSS --> .dp1 .dp2 .dp3 .dp4 .dp5 .T1 { } Asma AsmaArnas bidetako butxaketa itzulgarria eta errepikagarria Bronkioen gainaktibakortasuna + gainsentikortasuna Tratamendu etiologikoa•Alergeno ezagunak ekiditu •Narritatzaileak ekiditu •Zenbait farmako ekiditu (AINE-k) •Immunoterapia Tratamendu farmakologikoaAgonista 2 adrenergikoak Antikolinergikoak Kortikoideak Metilxantinak Mastozitoaren egonkortzaileak Leukotrienoen inhibitzaileak Agonista 2 adrenergikoak•Bronkouzkurduraren arindura eta ariketak sortutako asmaren prebentzioa •Eragin laburra (3-6 ordu) vs luzea (12 ordu) •Iraupen luzekoak (salmeterol, formoterol)  arazo larriak (intubazioa, ospitalizazioa, heriotza…) •Arrisku  4-11 urteko umeengan •↓ kortikoideekin •Behar izatekotan erabili, erabilera mugatua •Arnas bidez AntikolinergikoakAsma larrian agonista 2 adrenergikoen eraginkortasuna indartzeko Kortikoideak•Oinarrizko tratamendua asma moderatua, larria eta akutuan (arnas bidez) •Ahozko kandidiasia •Osteoporosia •Asma larria akutuan, aho bidez edo zain bidez Metilxantinak•Tarte terapeutiko estua (mail plasmatikoen monitarizazioa) •Ezin erabili arnas bidez (askapen luzeko sistemak) •Elkarrekintza ugari Mastozitoaren egonkortzaileak•Profilaxia •Eragin atzeratua (4-8 aste) •Haurren asma arina •Arnas bidetiko kortikoideak baino garestiagoak eta eraginkortasun gutxiago Leukotrienoen inhibitzaileak•LTD4-rako hartzaileen antagonistak (Zafirlukast, Montelukast) •5-lipooxigenasaren inhibitzaileak (Zileuton) •Ariketak sortutako asmaren prebentzioa helduetan •Asma iraunkorra moderatuan  arnas bideko esteroideen dosia EPOC EPOCArnas bidetako butxaketa kronikoa eta itzulezina Populazioaren %6-7 (65 urte gorako gizonengan %20) Arrisku faktore nagusiena tabakismoa Hantura, disfuntzio mukoziliarra, butxadura, egiturazko aldaketak Eztula, espektorazioa, disnea (batzuetan ronkus eta txistuak) Tratamenduaren helburuak Sintomak hobetzea Okertzeak edo berragerpenak ekiditzea Gaixotasunaren aurreratzea etetea Arnas funtzioa berreskuratzea Bizi iraupena eta bizi kalitatea hobetzea Tratamendua–Erretzeari utzi –Griperen aurkako txertoa urtero –Tratamendu farmakologikoa Tratamendu farmakologikoaArnas bideko bronkozabaltzaileak –Antikolinergikoak (2 baino seguruagoak eta eraginkortasuna =) –Agonistak 2 adrenergikoak (lehen aukerakoak disnea krisialdietan) Arnas bidetiko kortikoideak –Erantzun espirometriko argia duten pazienteengan –Gaizkiagotzean –  Neumonia arriskua Mukolitikoak –Eraginkortasun mugatua (subjetiboa) –Mukua fluidifikatzen dute baina ez dute kanporatzea bultzatzen Antibiotikoak –Aldi bereko infekzioan Etxeko oxigenoterapia  bizi iraupena hipoxemia duten pazienteengan
